SFRP2 is a tumor suppressor protein that can induce cell apoptosis, and differential methylation of its promoter region has been associated with leukemias and renal cancer (Jost et al., 2008; Konac et al., 2013; Li and Luo, 2018). Here, TCHP is linked to renal carcinoma.